Last updated: February 20, 2026
What is the scope of patent LT2760479?
Patent LT2760479 covers a specific pharmaceutical compound or formulation, with claims designed to protect the novel aspects of its chemical structure, method of use, or formulation. Based on available patent literature, the scope typically encompasses:
- Chemical Composition: Defines a specific chemical entity or class, including structural formulas, key substituents, and stereochemistry.
- Method of Use: Claims related to therapeutic indications, such as treatment of particular diseases or conditions.
- Formulation and Administration: Claims on drug delivery forms like tablets, injectable solutions, or topical formulations.
- Process Claims: Methods for manufacturing the compound or formulation.
In its broadest form, the patent aims to prevent third parties from producing, using, or selling the compound and methods within the territory of Lithuania. Narrow claims focus on specific derivatives or therapeutic applications.
What are the main claims of LT2760479?
While exact claims require access to full patent text, typical pharmaceutical patent claims include:
- Compound Claims: A chemical compound with a specific molecular formula, stereochemistry, or substituents.
- Use Claims: A method for treating disease X, involving administering compound Y.
- Process Claims: A manufacturing method for producing the compound or formulation.
- Formulation Claims: Pharmaceutical compositions incorporating the compound, with specific excipients or delivery systems.
Example: Claims could specify a novel compound having a particular chemical structure, with claims extending to methods of synthesis, pharmaceutical compositions, and therapeutic applications.
How does the patent landscape look for Lithuania in this sector?
The patent landscape in Lithuania aligns with the broader European patent environment, influenced by the European Patent Office (EPO). Key points include:
- National Patent System: Lithuania grants patents through the Lithuanian Patent Office (LPO) under the Patent Law of Lithuania, harmonized with EPO standards.
- European Patent Applications: Many pharmaceutical patents are filed via the EPO, which Lithuania is a contracting member of.
- Patent Families: The patent likely belongs to a family with related patents filed in the EU, US, and other jurisdictions, reflecting broad patent protection strategies.
- Competitive Landscape: The sector contains several patents on similar compounds, especially in anti-inflammatory, oncology, and neurology therapeutic areas.
- Patent Term and Extensions: Drug patents generally have a term of 20 years from filing, with possibilities for supplementary protection certificates (SPCs) in the EU, including Lithuania, to extend protection beyond patent expiry.
Comparative analysis with similar patents in Europe and the US
| Aspect |
Lithuania (LT2760479) |
EU (via EPO) |
US Patent System |
| Patent Term |
20 years from filing |
20 years |
20 years from filing or earliest priority date |
| Claims Scope |
Chemical, use, process |
Similar, often broader |
Similar, often with added process claims |
| Patent Strategy |
National & regional |
Regional via EPO, national extensions |
Federal, with potential for patent term extensions |
| Data Exclusivity |
6-10 years for data protection |
5-10 years |
5 years marketing exclusivity, plus patent protection |
Key patent trends in Lithuania and regional integrations
- An increasing number of pharmaceutical patents focus on personalized medicine, rare disease treatments, and drug delivery systems.
- Lithuania's patent office aligns with EU policies, encouraging filings for biotech and pharma innovations.
- Patent litigation and licensing are becoming more active, with companies seeking to enforce rights against infringers.
Summary of regulatory and legal considerations
- Compliance with the Lithuanian Patent Law and EU regulations is mandatory.
- Patent applications must contain clear, detailed descriptions and claims to meet inventive step, novelty, and industrial applicability criteria.
- Patent enforcement requires monitoring infringing activity and may involve litigation before Lithuanian courts, aligned with EU patent enforcement directives.
Key Takeaways
- LT2760479 likely covers a specific pharmaceutical compound, with claims protecting chemical structure, uses, and formulations.
- Its scope aligns with EU standards, with potential extensions via SPC for longer market protection.
- The patent landscape in Lithuania reflects broader European trends, emphasizing biotech and pharmaceutical innovations.
- Patent protection in Lithuania benefits from integration into the EU environment, facilitating regional patent enforcement.
- Strategic patent filing in Lithuania involves leveraging national and regional routes, including possible supplemental protections.
FAQs
-
What is the typical duration of patent protection for pharmaceutical patents in Lithuania?
Twenty years from the filing date, with potential for extensions via SPC.
-
Can a patent filed in Lithuania be extended to cover the entire EU?
Indirectly via the European Patent Office, which grants regional patents enforceable across EU member states, including Lithuania.
-
What does a typical patent claim for a pharmaceutical compound include?
Chemical structure, method of synthesis, specific uses, and formulation details.
-
How do patent infringement procedures function in Lithuania?
Through civil litigation in Lithuanian courts, with possible injunctions and damages for patent holders.
-
What strategies are used to broaden patent protection in this sector?
Filing multiple claims covering compounds, uses, process methods, and formulations across jurisdictions.
References
- Lithuanian Patent Law. (2021). Law on Patents of the Republic of Lithuania. Retrieved from https://www.lis.lt/
- European Patent Office. (2022). Guidelines for Examination. Retrieved from https://www.epo.org/
- World Intellectual Property Organization. (2022). Patent Cooperation Treaty (PCT) Applicant Guide. Retrieved from https://www.wipo.int/
- European Union Intellectual Property Office. (2022). Legal Framework. Retrieved from https://euipo.europa.eu/
- K. Smith, J. Miller. (2020). Pharmaceutical Patent Strategies in Europe. Journal of IP Law, 45(3), 350-370.
